Merit Medical SystemsFRA:MM3 +4.17%87 Days Payable is 29.55 as of Mar. 2026, which is 13% below its 10-year median of 34.14. GuruFocus rates FRA:MM3 with a GF Score™ of 87/100 and a GF Value™ of €84.32 (Modestly Undervalued). Among 796 Medical Devices & Instruments companies, Merit Medical Systems ranks worse than 85.18% on this metric.
The historical rank and industry rank for Merit Medical Systems's Days Payable or its related term are showing as below:
FRA:MM3'
s Days Payable Range Over the Past 10 Years
Min: 29.79 Med: 34.14 Max: 36.95
Current: 30.07
During the past 13 years, Merit Medical Systems's highest Days Payable was 36.95. The lowest was 29.79. And the median was 34.14.
FRA:MM3's Days Payable is ranked worse than 85.18% of 796
companies
in the Medical Devices & Instruments industry
Industry Median: 68.14
vs FRA:MM3: 30.07
Merit Medical Systems Days Payable Historical Data
* Premium members only.
The historical data trend for Merit Medical Systems's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:MM3 vs NVST, MMED, ICUI: Days Payable Comparison
For the Medical Instruments & Supplies subindustry, Merit Medical Systems's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Merit Medical Systems Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Merit Medical Systems's Days Payable distribution charts can be found below:
* The bar in red indicates where Merit Medical Systems's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Merit Medical Systems's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Merit Medical Systems (FRA:MM3) has a Days Payable of 29.55 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Merit Medical Systems and its competitors. This is 13% below median its historical median of 34.14. Over the past decade, Merit Medical Systems' Days Payable has ranged from 29.79 to 36.95. According to the industry distribution chart, Merit Medical Systems ranks #678 out of 796 companies in the Medical Devices & Instruments industry, placing it in the top 85.2%.
Is Merit Medical Systems' Days Payable too high?
Merit Medical Systems' current Days Payable of 29.55 is 13% below median its 10-year median of 34.14. Over the past 10 years, this metric has ranged from a low of 29.79 to a high of 36.95. The Medical Devices & Instruments industry median Days Payable is 68.14. Merit Medical Systems' value of 29.55 is 56.6% below this industry median. Based on the distribution chart, Merit Medical Systems ranks #678 out of 796 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Merit Medical Systems has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Merit Medical Systems' Days Payable compare to NVST and MMED?
According to the Medical Devices & Instruments industry distribution chart, Merit Medical Systems ranks #678 out of 796 companies for Days Payable. This places Merit Medical Systems in the lower half of its industry. The industry median Days Payable is 68.14. Merit Medical Systems' value of 29.55 is 56.6% below this benchmark. Historically, Merit Medical Systems' own Days Payable has ranged from 29.79 to 36.95 over the past decade. While the company's 10-year median is 34.14 vs. the industry median of 68.14, Merit Medical Systems has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.14, based on 796 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Merit Medical Systems's current Days Payable of 29.55 is 56.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Merit Medical Systems and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Merit Medical Systems's current Days Payable is 29.55, which is 13% below median its own 10-year median of 34.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Merit Medical Systems stock overvalued right now?
Based on GuruFocus' analysis, Merit Medical Systems (FRA:MM3) is currently considered Modestly Undervalued. The stock's GF Value™ is €84.32, compared to a current price of €62.50 — trading 25.9% below its estimated fair value. The current Days Payable is 29.55, which is 13% below median its 10-year median of 34.14 and 56.6% below the Medical Devices & Instruments industry median of 68.14. Merit Medical Systems' overall GF Score™ is 87/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Merit Medical Systems (FRA:MM3), the current Days Payable is 29.55 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Merit Medical Systems (FRA:MM3) Overvalued in 2026?
Based on GuruFocus' analysis, Merit Medical Systems stock appears to be undervalued.
The current stock price of €62.50 is trading 25.9% below its estimated GF Value™ of €84.32.
GuruFocus considers Merit Medical Systems to be Modestly Undervalued.
Key valuation signals for FRA:MM3:
Days Payable: 29.55 (13% below median its 10-year median of 34.14)
GF Value™: €84.32 vs. price of €62.50 (25.9% below fair value)
Industry Position: 56.6% below the Medical Devices & Instruments median (#678 of 796)
No single metric tells the full story. See the FRA:MM3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.
87GF Score
Get the complete analysis for FRA:MM3
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:MM3 has been successfully added to your 
